Daniel Rohle
Impact in
- Genetics top 0.2%
- Glioma Diagnosis and Treatment
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
- Genetics 5
- Glioma Diagnosis and Treatment 5
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Ingo K. Mellinghoff (5 shared papers)Craig B. Thompson (3 shared papers)Timothy An-thy Chan (3 shared papers)Chao Lü (2 shared papers)Şevin Turcan (2 shared papers)Patrick S. Ward (2 shared papers)Ross L. Levine (2 shared papers)Donald M. O’Rourke (1 shared paper)
- Journals
- Nature (2 papers)Cancer Discovery (2 papers)Proceedings of the National Academy of Sciences (2 papers)Life Science Alliance (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Daniel Rohle
14 papers receiving 5.5k citations
Daniel Rohle's Hit Papers
Peers
Comparison fields: 5 of 90
- Genetics 2.4k
- Cancer Research 1.3k
- Hematology 479
- Molecular Biology 1.3k
- Biochemistry 120
Countries citing papers authored by Daniel Rohle
This map shows the geographic impact of Daniel Rohle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rohle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rohle more than expected).
Fields of papers citing papers by Daniel Rohle
This network shows the impact of papers produced by Daniel Rohle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rohle. The network helps show where Daniel Rohle may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Rohle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | IDH mutation impairs histone demethylation and results in a block to cell differentiation Hit paper breakdown → | 2012 | 1654 |
| 2 | IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype Hit paper breakdown → | 2012 | 1611 |
| 3 | An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells Hit paper breakdown → | 2013 | 986 |
| 4 | Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma Hit paper breakdown → | 2017 | 325 |
| 5 | 2012 | 288 | |
| 6 | 2015 | 272 | |
| 7 | 2009 | 236 | |
| 8 | 2011 | 103 | |
| 9 | 2010 | 93 | |
| 10 | 2017 | 27 | |
| 11 | 2022 | 13 | |
| 12 | 2007 | 8 | |
| 13 | 2009 | 8 | |
| 14 | Effects of the Curves® fitness & weight loss program VI:insulin sensitivity | 2004 | 1 |
| 15 | 2026 | 0 |
About Daniel Rohle
Daniel Rohle is a scholar working on Genetics, Cancer Research, Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 15 papers that have together received 5.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), HER2/EGFR in Cancer Research (3 papers), DNA Repair Mechanisms (2 papers), Epigenetics and DNA Methylation (1 paper), Protein Tyrosine Phosphatases (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Hormonal and reproductive studies (1 paper). The work is most often cited by research in Genetics (2.4k citations), Cancer Research (1.3k citations), Hematology (479 citations), Molecular Biology (1.3k citations) and Biochemistry (120 citations). Daniel Rohle has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Ingo K. Mellinghoff, Craig B. Thompson, Timothy An-thy Chan, Chao Lü, Şevin Turcan, Patrick S. Ward, Ross L. Levine, Donald M. O’Rourke, Christopher R. Edwards and Omar Ibrahim Abdel-Wahab. Their work appears in journals such as Nature, Cancer Discovery, Proceedings of the National Academy of Sciences, Life Science Alliance and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.